Vaccine policy in the United States is going through a period of change — and for many patients, that change is creating confusion.

In this episode of The Health Advocates, Steven Newmark breaks down a series of recent developments that are reshaping how vaccines are reviewed, recommended, and discussed. From the FDA’s decision not to review a new mRNA flu vaccine, to shifting federal guidance around vaccine recommendations, to new data showing declining public confidence, the conversation connects the dots across what can otherwise feel like isolated headlines.

The episode also explores the growing legal challenge to recent changes in vaccine policy and what it signals about the broader direction of public health decision-making. Most importantly, it focuses on what all of this means for patients — including how to navigate mixed messages, where to turn for reliable information, and why the doctor-patient relationship is becoming more important than ever.

This is a moment of transition in public health. And for patients, understanding that shift is key to making informed decisions.

Contact Our Host

Steven Newmark, Chief of Policy at GHLF: snewmark@ghlf.org

A podcast episode produced by Amelia Violet Prouse, Associate Podcast & Video Producer at GHLF.

We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.org

Listen to all episodes of The Health Advocates on our website or on your favorite podcast channel.